Answers are grounded in this paper and cite their sources.
Background Hereditary cystic kidney diseases (CysKDs) are increasingly recognized as multisystem disorders with neurodevelopmental involvement. Previous studies have reported elevated symptoms of autism spectrum disorder (ASD) in specific CysKDs, but whether these elevations correspond to confirmed ASD diagnoses remains unclear. Method We assessed social-communication difficulties and broader autistic symptom burden in a multicenter cohort of 100 individuals aged 1–24 years with genetically confirmed CysKDs, including Bardet–Biedl syndrome (BBS; n = 37), HNF1B deletions ( n = 24), intragenic HNF1B pathogenetic variants ( n = 7), and other rare CysKDs. All participants underwent standardized questionnaire-based phenotyping; a subsample of 21 additionally received in-depth ASD diagnostics using ADOS-2 and ADI-R. Results Individuals with HNF1B deletions showed greater symptoms of ASD burden than those with intragenic variants, including more pronounced impairments in social responsiveness ( p = .041, d = 1.01) and social communication ( p = .040, d = 0.71). Exploratory analyses further showed greater social-responsiveness difficulties in BBS and HNF1B deletion groups compared with other CysKDs, F (2,87) = 6.44, p = .003. Importantly, elevated screening-based symptom burden did not uniformly correspond to a confirmed ASD diagnosis in the in-depth diagnostic subsample. ADOS-2 severity did not differ significantly between BBS ( n = 11) and HNF1B deletions ( n = 9). Conclusions These findings confirm substantial symptoms of ASD burden in BBS and HNF1B -associated disease but demonstrate that screening elevations should not be equated with ASD diagnosis. Comprehensive diagnostic assessment is therefore warranted following positive screening
No takes yet. Share an insight, caveat, or question.
Nittel et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: